SUBSCRIBE: Print / eNewsletter
Noninvasive Test Detected Colorectal Neoplasia in Non-compliant Patients
The use of a noninvasive colorectal cancer screening test called a multi-target stool DNA test (mt-sDNA) detected the disease in patients who had previously avoided more invasive screening procedures.
Neoadjuvant Anti-HER2 Combo Could Trump Chemo/Trastuzumab
Results of the I-SPY 2 TRIAL found that the neoadjuvant combination of T-DM1 plus pertuzumab resulted in a greater benefit to HER2-positive breast cancer patients compared with paclitaxel plus trastuzumab.
Oral Bacteria Linked With Pancreatic Cancer
Researchers have identified two species of bacteria linked with periodontal disease in healthy individuals that are associated with a risk of developing pancreatic cancer.
Nivolumab New Care Option for Head and Neck Cancer
Immunotherapy treatment with nivolumab significantly improved survival among patients with recurrent or metastatic head and neck squamous cell carcinoma.
Maintaining High Physical Activity Improves Prostate Cancer Survival
Prostate cancer patients who kept up a moderate to high level of physical activity had better survival prognoses compared with their more sedentary counterparts.
CD4 T-Cell Immunotherapy Active in Various Cancers
Results of a trial involving a CD4-based immunotherapy has shown activity in patients with metastatic solid tumors, according to phase I data presented at the AACR Annual Meeting.
Robust 5-Year Survival With Nivolumab for Metastatic Melanoma
More than one-third of patients with advanced melanoma were still alive 5 years after starting treatment with the anti-PD-1 immunotherapy nivolumab, according to long-term phase I data.
Entrectinib Active Against Cancers With Various Gene Rearrangements
New data indicates that entrectinib has clinical activity in patients with a variety of cancers with gene alterations in NTRK1/2/3, ROS1, or ALK who had never been treated with targeted agents.